Increased reactivity of platelets induced by fibrinogen independent of its binding to the IIb-IIIa surface glycoprotein: A potential contributor to cardiovascular risk

Journal of the American College of Cardiology

Volumn 33, Issue 1, 1999, Pages 261-266

  Schneider, David J ^a   Taatjes, Douglas J ^a   Howard, Diantha B ^a   Sobel, Burton E ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; FIBRINOGEN; FIBRINOGEN RECEPTOR AFFECTING AGENT; PADGEM PROTEIN;

ARTICLE; CONTROLLED STUDY; CORONARY RISK; DEGRANULATION; HEART INFARCTION; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION;

EID: 0032952035     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00515-4     Document Type: Article

References (30)

1. Kannel W.B., Wolf P.A., Castelli W.P., D'Agostino R.B. Fibrinogen and risk of cardiovascular disease the Framingham Study . JAMA. 258:1987;1183-1186.
2. Wilhelmensen L., Svärdsudd K., Korsan-Bengsten K., Larsson B., Welin L., Tiblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 311:1984;501-505.
3. Meade T.W., North W.R., Chakrabarti R., Stirling Y., Haines A.P., Thompson S.G., et al. Hemostatic function and ischemic heart disease principal results of the Northwick Park Heart Study . Lancet. 2:1986;533-537.
4. Baker I.A., Eastham R., Elwood P.C., Etherington M., O'Brian J.R., Sweetham P.M. Haemostatic factors associated with ischaemic heart disease in men aged 45-64 years the Speedwell Study . Br Heart J. 47:1982;490-494.
5. Yarnell J.W., Baker I.A., Sweetnam P.M., Bainton D., O'Brien J.R., Whitehead P.J., et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. Circulation. 83:1991;836-844.
6. Chooi C.C., Gallus A. Acute phase reaction, fibrinogen level and thrombus size. Thromb Res. 53:1989;493-501.
7. Naski M.C., Shafer J.A. A kinetic model for the α-thrombin-catalyzed conversion of plasma levels of fibrinogen to fibrin in the presence of antithrombin III. J Biol Chem. 266:1991;13003-13010.
8. Meade T.W., Vickers M.V., Thompson S.G., Seghatchian M.J. The effect of physiological levels of fibrinogen on platelet aggregation. Thromb Res. 38:1985;527-534.
9. Sims P.J., Ginsberg M.H., Plow E.F., Shattil S.J. Effect of platelet activation on the conformation of the plasma membrane glycoprotein IIb-IIIa complex. J Biol Chem. 266:1991;7345-7352.
10. Monroe D.M., Roberts H.R., Hoffman M. Platelet procoagulant complex assembly in a tissue factor-initiated system. Br J Haemotol. 88:1994;364-371.
11. McEver R.P., Martin M.N. A monoclonal antibody to a membrane glycoprotein binds only to activated platelets. J Biol Chem. 259:1984;9799-9804.
12. Schneider D.J., Tracy P.B., Mann K.G., Sobel B.E. Differential effects of anticoagulants on the activation of platelets ex vivo. Circulation. 96:1997;2877-2883.
13. Rand M.D., Lock J.B., Veer C.V., Gaffney D.P., Mann K.G. Blood clotting in minimally altered whole blood. Blood. 88:1996;3432-3445.
14. Clauss A. Human fibrinogen heterogeneities I Physiological clotting fast method for fibrinogen determination . Acta Haematologica. 17:1957;237-246.
15. Xia V., Wong T., Liu Q., Kasirer-Friede A., Brown E., Frojmovic M.M. Optimally functional flouroscein isothiocyanate-labeled fibrinogen for quantitative studies of binding to activated platelets and platelet aggregation. Br J Haematol. 93:1996;204-214.
16. McDonald L., Edgill M. Coagulability of the blood in ischaemic heart disease. Lancet. 2:1957;457-460.
17. Marguerie G.A., Edgington T.S., Plow E.F. Interaction of fibrinogen with its platelet receptor as part of a multistep reaction in ADP-induced platelet aggregation. J Biol Chem. 255:1980;154-160.
18. Handagama P., Rappolee D.A., Werb Z., Levin J., Bainton D.F. Platelet α-granule fibrinogen, albumin, and immunoglobulin G are not synthesized by rat and mouse megakaryocytes. J Clin Invest. 86:1990;1364-1368.
19. Louarche F., Debili N., Cramer E., Breton-Gorius J., Vainchenker W. Fibrinogen is not synthesized by human megakaryocytes. Blood. 77:1991;311-316.
20. Handagama P., Shuman M.A., Bainton D.F. Incorporation of intravenously injected albumin, immunoglobulin G, and fibrinogen in guinea pig megakaryocyte granules. J Clin Invest. 84:1989;73-82.
21. Harrison P., Wilbourn B.R., Debili N., Vainchenker W., Breton-Gorius J., Lawrie A.S., et al. Uptake of plasma fibrinogen into the α-granules of human megakaryocytes and platelets. J Clin Invest. 84:1989;1320-1324.
22. Handagama P., Bainton D.F., Jacques Y., Conn M.T., Lazarus R.A., Shuman M.A. Kistrin, an integrin antagonist, blocks endocytosis of fibrinogen into guinea pig megakaryocyte and platelet α-granules. J Clin Invest. 91:1993;193-200.
23. Harrison P., Wilbourn B., Cramer E., Faint R., Mackie I.J., Bhattacharya S., et al. The influence of therapeutic blocking of GP IIb/IIIa on platelet α-granular fibrinogen. Br J Haematol. 82:1992;721-728.
24. 3 integrin receptors a potential mechanism for the prevention of restenosis . J Am Coll Cardiol. 29:1997;243A.
25. Ridker P.M., Cushman M., Stampfer M.J., Russell R.P., Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 336:1997;973-979.
26. Saikku P., Leinonen M., Mattila K.J., Ekman M.R., Nieminen M.S., Makela P.H., et al. Serological evidence of an association of novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 2:1988;983-986.
27. Gupta S., Leatham E.W., Carrington D., Mendall M.A., Kaski J.C., Camm A.J. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation. 96:1997;404-407.
28. Melnick J.L., Adam E., Debakey M.E. Possible role of cytomegalovirus in atherogenesis. JAMA. 263:1990;2204-2207.
29. Mendall M.A., Goggin P.M., Molineaux N., et al. Relation of Helibacter pylori infection and coronary heart disease. Br Heart J. 71:1994;437-439.
30. Janes S.L., Goodall A.H. Flow cytometric detection of circulating activated platelets and platelet hyper-responsiveness in pre-eclampsia and pregnancy. Clin Sci. 86:1994;731-739.